Literature DB >> 26604321

Evidence for a heritable contribution to neuroendocrine tumors of the small intestine.

Deborah W Neklason1, James VanDerslice2, Karen Curtin3, Lisa A Cannon-Albright4.   

Abstract

Small intestinal neuroendocrine tumors (SI-NETs) are rare tumors arising from the enterochromaffin cells of the gut. Having a first-degree relative with a SI-NET has been shown to confer a substantial risk arising from shared environment and genetics. Heritable risk was examined using a computerized genealogy linked to historical statewide cancer data. A population-based analysis of the observed familial clustering of SI-NETs was performed to assess the genetic risk in distant relatives. A test for significant excess relatedness of 384 individuals with genealogy data and histologically confirmed SI-NETs was performed by comparing pairwise relatedness of cases to 1000 sets of matched controls. Overall significant excess pairwise relatedness was found for the 384 cases (P<0.001) and was still observed when closer than first cousin relationships were ignored (P=0.041). Relative risks (RRs) for SI-NETs were estimated as a ratio of observed to expected number of SI-NET cases among each relationship class. Siblings have a 13.4-fold (P<0.0001) and parents have a 6.5-fold (P=0.143) RR, suggesting both genetic and environmental influences. The risk extends out to third-degree relatives with a 2.3-fold RR (P=0.008). Metachronous cancers were also reported in 26% of the SI-NET cases demonstrating an increased RR of colon, bladder, non-Hodgkin lymphoma, melanoma, and prostate cancers. Although SI-NETs are rare, relatives of these cases are at a significantly elevated risk of developing a SI-NET due to heritable genetic factors. Definition of the genetic risk factors will be an important tool for earlier diagnosis and better outcomes for SI-NETs.
© 2016 Society for Endocrinology.

Entities:  

Keywords:  familial; genetics; neuroendocrine tumor; population; relative risk; small intestine

Mesh:

Year:  2015        PMID: 26604321      PMCID: PMC4684974          DOI: 10.1530/ERC-15-0442

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  20 in total

1.  Inbreeding in the Utah Mormons: an evaluation of estimates based on pedigrees, isonymy, and migration matrices.

Authors:  L B Jorde
Journal:  Ann Hum Genet       Date:  1989-10       Impact factor: 1.670

2.  Correlation between genetic and geographic structure in Europe.

Authors:  Oscar Lao; Timothy T Lu; Michael Nothnagel; Olaf Junge; Sandra Freitag-Wolf; Amke Caliebe; Miroslava Balascakova; Jaume Bertranpetit; Laurence A Bindoff; David Comas; Gunilla Holmlund; Anastasia Kouvatsi; Milan Macek; Isabelle Mollet; Walther Parson; Jukka Palo; Rafal Ploski; Antti Sajantila; Adriano Tagliabracci; Ulrik Gether; Thomas Werge; Fernando Rivadeneira; Albert Hofman; André G Uitterlinden; Christian Gieger; Heinz-Erich Wichmann; Andreas Rüther; Stefan Schreiber; Christian Becker; Peter Nürnberg; Matthew R Nelson; Michael Krawczak; Manfred Kayser
Journal:  Curr Biol       Date:  2008-08-07       Impact factor: 10.834

3.  Genetic structure of the Utah Mormons: isonymy analysis.

Authors:  L B Jorde; K Morgan
Journal:  Am J Phys Anthropol       Date:  1987-03       Impact factor: 2.868

4.  Genetic distances between the Utah Mormons and related populations.

Authors:  T McLellan; L B Jorde; M H Skolnick
Journal:  Am J Hum Genet       Date:  1984-07       Impact factor: 11.025

5.  Impact of the LDS church's health doctrine on deaths from diseases and conditions associated with cigarette smoking.

Authors:  Ray M Merrill; Sterling C Hilton; Melissa Daniels
Journal:  Ann Epidemiol       Date:  2003-11       Impact factor: 3.797

Review 6.  One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.

Authors:  James C Yao; Manal Hassan; Alexandria Phan; Cecile Dagohoy; Colleen Leary; Jeannette E Mares; Eddie K Abdalla; Jason B Fleming; Jean-Nicolas Vauthey; Asif Rashid; Douglas B Evans
Journal:  J Clin Oncol       Date:  2008-06-20       Impact factor: 44.544

7.  Small bowel cancer: epidemiological and clinical characteristics from a population-based registry.

Authors:  J A DiSario; R W Burt; H Vargas; W P McWhorter
Journal:  Am J Gastroenterol       Date:  1994-05       Impact factor: 10.864

8.  Familial gastrointestinal carcinoid tumours and associated cancers.

Authors:  E Hiripi; J Lorenzo Bermejo; J Sundquist; K Hemminki
Journal:  Ann Oncol       Date:  2009-01-15       Impact factor: 32.976

9.  A comprehensive survey of cancer risks in extended families.

Authors:  Craig C Teerlink; Frederick S Albright; Lauro Lins; Lisa A Cannon-Albright
Journal:  Genet Med       Date:  2012-01       Impact factor: 8.822

Review 10.  Significant evidence for a heritable contribution to cancer predisposition: a review of cancer familiality by site.

Authors:  Frederick Albright; Craig Teerlink; Theresa L Werner; Lisa A Cannon-Albright
Journal:  BMC Cancer       Date:  2012-04-03       Impact factor: 4.430

View more
  8 in total

1.  Associations of Tobacco and Alcohol Use with Risk of Neuroendocrine Tumors of the Small Intestine in Utah.

Authors:  Karen Curtin; Lisa A Cannon-Albright; James VanDerslice; Zhe Yu; Kimberly A Herget; Ramya Thota; Deborah W Neklason
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-09-26       Impact factor: 4.254

2.  TSC2 rare germline variants in non-tuberous sclerosis patients with neuroendocrine neoplasias.

Authors:  Paula Fontes Asprino; Rudinei Diogo Marques Linck; Jônatas Cesar; Florêncio Porto Freitas; Fernanda Christtanini Koyama; Rachel Simões Pimenta Riechelmann; Frederico Perego Costa; Paulo Marcelo Gehm Hoff; Pedro Alexandre Favoretto Galante; Diogo Meyer; Anamaria Aranha Camargo; Jorge Sabbaga
Journal:  Endocr Relat Cancer       Date:  2017-11-22       Impact factor: 5.678

3.  A MUTYH germline mutation is associated with small intestinal neuroendocrine tumors.

Authors:  Jan P Dumanski; Chiara Rasi; Peyman Björklund; Hanna Davies; Abir S Ali; Malin Grönberg; Staffan Welin; Halfdan Sorbye; Henning Grønbæk; Janet L Cunningham; Lars A Forsberg; Lars Lind; Erik Ingelsson; Peter Stålberg; Per Hellman; Eva Tiensuu Janson
Journal:  Endocr Relat Cancer       Date:  2017-06-20       Impact factor: 5.678

Review 4.  Landscape of CDKN1B Mutations in Luminal Breast Cancer and Other Hormone-Driven Human Tumors.

Authors:  Martina Cusan; Giorgia Mungo; Mara De Marco Zompit; Ilenia Segatto; Barbara Belletti; Gustavo Baldassarre
Journal:  Front Endocrinol (Lausanne)       Date:  2018-07-17       Impact factor: 5.555

5.  Early life exposures associated with risk of small intestinal neuroendocrine tumors.

Authors:  James VanDerslice; Marissa C Taddie; Karen Curtin; Caroline Miller; Zhe Yu; Rachael Hemmert; Lisa A Cannon-Albright; Deborah W Neklason
Journal:  PLoS One       Date:  2020-04-23       Impact factor: 3.240

Review 6.  Clinical Features, Management, and Molecular Characteristics of Familial Small Bowel Neuroendocrine Tumors.

Authors:  James Y Lim; Rodney F Pommier
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-26       Impact factor: 5.555

7.  Loss of copy of MIR1-2 increases CDK4 expression in ileal neuroendocrine tumors.

Authors:  Tanupriya Contractor; Chris R Harris
Journal:  Oncogenesis       Date:  2020-03-20       Impact factor: 7.485

8.  WNT2 activation through proximal germline deletion predisposes to small intestinal neuroendocrine tumors and intestinal adenocarcinomas.

Authors:  Mervi Aavikko; Eevi Kaasinen; Noora Andersson; Nalle Pentinmikko; Päivi Sulo; Iikki Donner; Päivi Pihlajamaa; Anna Kuosmanen; Simona Bramante; Riku Katainen; Lauri J Sipilä; Samantha Martin; Johanna Arola; Olli Carpén; Ilkka Heiskanen; Jukka-Pekka Mecklin; Jussi Taipale; Ari Ristimäki; Kaisa Lehti; Erika Gucciardo; Pekka Katajisto; Camilla Schalin-Jäntti; Pia Vahteristo; Lauri A Aaltonen
Journal:  Hum Mol Genet       Date:  2021-11-30       Impact factor: 6.150

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.